SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-23-011640
Filing Date
2023-04-28
Accepted
2023-04-28 16:30:26
Documents
94
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A sabs20211231_10ka.htm   iXBRL 10-K/A 1376927
2 EXHIBIT 23.1 ex_508394.htm EX-23.1 2778
3 EXHIBIT 31.1 ex_508764.htm EX-31.1 14669
4 EXHIBIT 31.2 ex_508765.htm EX-31.2 14404
5 EXHIBIT 32.1 ex_508804.htm EX-32.1 6800
6 EXHIBIT 32.2 ex_508805.htm EX-32.2 6309
  Complete submission text file 0001437749-23-011640.txt   9508942

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA sabs-20211231.xsd EX-101.SCH 94845
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sabs-20211231_def.xml EX-101.DEF 623617
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sabs-20211231_lab.xml EX-101.LAB 532857
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sabs-20211231_pre.xml EX-101.PRE 671316
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sabs-20211231_cal.xml EX-101.CAL 66340
88 EXTRACTED XBRL INSTANCE DOCUMENT sabs20211231_10ka_htm.xml XML 1750188
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39871 | Film No.: 23867019
SIC: 2836 Biological Products, (No Diagnostic Substances)